These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 20704209)

  • 21. Removal of residual pharmaceuticals from aqueous systems by advanced oxidation processes.
    Klavarioti M; Mantzavinos D; Kassinos D
    Environ Int; 2009 Feb; 35(2):402-17. PubMed ID: 18760478
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fate of pharmaceutical and personal care products (PPCPs) during anaerobic digestion of sewage sludge.
    Carballa M; Omil F; Ternes T; Lema JM
    Water Res; 2007 May; 41(10):2139-50. PubMed ID: 17399761
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Direct and indirect photolysis of sulfamethoxazole and trimethoprim in wastewater treatment plant effluent.
    Ryan CC; Tan DT; Arnold WA
    Water Res; 2011 Jan; 45(3):1280-6. PubMed ID: 21044793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Electrochemical oxidation of trace organic contaminants in reverse osmosis concentrate using RuO2/IrO2-coated titanium anodes.
    Radjenovic J; Bagastyo A; Rozendal RA; Mu Y; Keller J; Rabaey K
    Water Res; 2011 Feb; 45(4):1579-86. PubMed ID: 21167547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Occurrence and removal of pharmaceuticals and endocrine disruptors in South Korean surface, drinking, and waste waters.
    Kim SD; Cho J; Kim IS; Vanderford BJ; Snyder SA
    Water Res; 2007 Mar; 41(5):1013-21. PubMed ID: 16934312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment.
    Radjenović J; Petrović M; Barceló D
    Water Res; 2009 Feb; 43(3):831-41. PubMed ID: 19091371
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Similarities in effluent organic matter characteristics from Connecticut wastewater treatment plants.
    Quaranta ML; Mendes MD; MacKay AA
    Water Res; 2012 Feb; 46(2):284-94. PubMed ID: 22104296
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ozonation: a tool for removal of pharmaceuticals, contrast media and musk fragrances from wastewater?
    Ternes TA; Stüber J; Herrmann N; McDowell D; Ried A; Kampmann M; Teiser B
    Water Res; 2003 Apr; 37(8):1976-82. PubMed ID: 12697241
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fate of pharmaceuticals in contaminated urban wastewater effluent under ultrasonic irradiation.
    Naddeo V; Meriç S; Kassinos D; Belgiorno V; Guida M
    Water Res; 2009 Sep; 43(16):4019-27. PubMed ID: 19589554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ozonation kinetics of winery wastewater in a pilot-scale bubble column reactor.
    Lucas MS; Peres JA; Lan BY; Li Puma G
    Water Res; 2009 Apr; 43(6):1523-32. PubMed ID: 19157490
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heterogenous photocatalytic degradation kinetics and detoxification of an urban wastewater treatment plant effluent contaminated with pharmaceuticals.
    Rizzo L; Meric S; Guida M; Kassinos D; Belgiorno V
    Water Res; 2009 Sep; 43(16):4070-8. PubMed ID: 19596131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serial mixed-mode cation- and anion-exchange solid-phase extraction for separation of basic, neutral and acidic pharmaceuticals in wastewater and analysis by high-performance liquid chromatography-quadrupole time-of-flight mass spectrometry.
    Lavén M; Alsberg T; Yu Y; Adolfsson-Erici M; Sun H
    J Chromatogr A; 2009 Jan; 1216(1):49-62. PubMed ID: 19054521
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Behavior of pharmaceuticals, cosmetics and hormones in a sewage treatment plant.
    Carballa M; Omil F; Lema JM; Llompart M; García-Jares C; Rodríguez I; Gómez M; Ternes T
    Water Res; 2004 Jul; 38(12):2918-26. PubMed ID: 15223286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Occurrence and reductions of pharmaceuticals and personal care products and estrogens by municipal wastewater treatment plants in Ontario, Canada.
    Lishman L; Smyth SA; Sarafin K; Kleywegt S; Toito J; Peart T; Lee B; Servos M; Beland M; Seto P
    Sci Total Environ; 2006 Aug; 367(2-3):544-58. PubMed ID: 16697441
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathways and metabolites of microbial degradation of selected acidic pharmaceutical and their occurrence in municipal wastewater treated by a membrane bioreactor.
    Quintana JB; Weiss S; Reemtsma T
    Water Res; 2005 Jul; 39(12):2654-64. PubMed ID: 15979124
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Removal of pharmaceuticals and fragrances in biological wastewater treatment.
    Joss A; Keller E; Alder AC; Göbel A; McArdell CS; Ternes T; Siegrist H
    Water Res; 2005 Sep; 39(14):3139-52. PubMed ID: 16043210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Removal of polycyclic synthetic musks and antineoplastic drugs in ozonated wastewater: Quantitation based on the data of differential spectroscopy.
    Li W; Nanaboina V; Chen F; Korshin GV
    J Hazard Mater; 2016 Mar; 304():242-50. PubMed ID: 26555374
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Electrochemical oxidation of textile wastewater and its reuse.
    Mohan N; Balasubramanian N; Basha CA
    J Hazard Mater; 2007 Aug; 147(1-2):644-51. PubMed ID: 17336454
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmaceuticals and other organic chemicals in selected north-central and northwestern Arkansas streams.
    Haggard BE; Galloway JM; Green WR; Meyer MT
    J Environ Qual; 2006; 35(4):1078-87. PubMed ID: 16738393
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Upflow anaerobic sludge blanket reactor--a review.
    Bal AS; Dhagat NN
    Indian J Environ Health; 2001 Apr; 43(2):1-82. PubMed ID: 12397675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.